Chinese Health announced on December 8 that Jiangsu Shenhua Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the “Notice of Acceptance” of the registration and marketing license application for lactulose oral solution drugs issued by the State Drug Administration. Lactulose oral solution is a laxative. Its main characteristics are fast laxative, gentle and effective, and highly safe. It is suitable for people with long-term chronic or habitual constipation. According to the requirements of laws and regulations relating to national drug registration, the above drug registration and marketing license application was accepted, indicating that the variety has entered the registration review stage. The completion time, approval results, and the specific sales situation of the drug after approval are uncertain, and will not have a significant impact on the company's short-term performance.

Chinese Health announced on December 8 that Jiangsu Shenhua Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the “Notice of Acceptance” of the registration and marketing license application for lactulose oral solution drugs issued by the State Drug Administration. Lactulose oral solution is a laxative. Its main characteristics are fast laxative, gentle and effective, and highly safe. It is suitable for people with long-term chronic or habitual constipation. According to the requirements of laws and regulations relating to national drug registration, the above drug registration and marketing license application was accepted, indicating that the variety has entered the registration review stage. The completion time, approval results, and the specific sales situation of the drug after approval are uncertain, and will not have a significant impact on the company's short-term performance.